1. Overcoming physical stromal barriers to cancer immunotherapy
   Seung Woo Chung et al, 2021, Drug Delivery and Translational Research CrossRef
2. Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression
   Eileena F. Giurini et al, 2022, Cancers CrossRef
3. Synthetic Toll-like receptor 7 ligand inhibits porcine reproductive and respiratory syndrome virus infection in primary porcine alveolar macrophages
   Yongkun Du et al, 2016, Antiviral Research CrossRef
4. Immunomodulatory and Antitumor Effects of a Novel TLR7 Agonist Combined with Lapatinib
   Ningning Gao et al, 2016, Scientific Reports CrossRef
5. Anti-tumor Activity of Toll-Like Receptor 7 Agonists
   Huju Chi et al, 2017, Frontiers in Pharmacology CrossRef
6. Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
   Cindy Patinote et al, 2020, European Journal of Medicinal Chemistry CrossRef
7. Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
   Samik Chakraborty et al, 2023, Frontiers in Immunology CrossRef